On the other hand, we found that high levels of ULBP1 ligand on BM myeloma cells correlated with reduced expression of NKG2D on CD56bright NK cells in peripheral blood (Figure 3B), suggesting ligand-induced downregulation. This evidence concerns the gene ULBP1 and plasma cell myeloma.